Pennsylvania Code › Title 55 - HUMAN SERVICES › Part III - MEDICAL ASSISTANCE MANUAL › Chapter 1241 - EARLY AND PERIODIC SCREENING, DIAGNOSIS AND TREATMENT PROGRAM › ADMINISTRATIVE SANCTIONS › Appendix D - EPSDT IMMUNIZATION GUIDELINES- STATEMENT OF POLICY

Current through Register Vol. 54, No. 28, July 13, 2024
Recommended Childhood Immunization
					 Schedule
United States, January-December 1997
Click to view
					 image
Approved by the Advisory Committee on Immunization
					 Practices (ACIP), the American Academy of Pediatrics (AAP), and the American
					 Academy of Family Physicians (AAFP).
1 This schedule indicates the
					 recommended age for routine administration of currently licensed childhood
					 vaccines. Some combination vaccines are available and may be used whenever
					 administration of all components of the vaccine is indicated. Providers should
					 consult the manufacturers' package inserts for detailed recommendations.
2
Infants born to
					 HBsAg-negative mothers
should receive 2.5 µg of Merck vaccine
					 (Recombivax HB) or 10 µg of SmithKline Beecham (SB) vaccine (Engerix-).
					 The 2nd dose should be administered >= 1 mo after 1st dose.
Infants born to HBsAg-positive mothers
should receive 0.5 mL hepatitis B immune globulin (HBIG) within 12 hrs of
					 birth, and either 5 µg of Merck vaccine (Recombivax HB) or 10 µg of
					 SB vaccine (Engerix-B) at a separate site. The 2nd dose is recommended at 1-2
					 mos of age and the 3rd dose at 6 mos of age.
Infants born to mothers whose HbsAg status is
					 unknown
should receive either 5 µg of Merck vaccine (Recombivax
					 HB) or 10 µg of SB vaccine (Engerix-B) within 12 hrs of birth. The 2nd
					 dose of vaccine is recommended at 1 mo of age and the 3rd dose at 6 mos of age.
					 Blood should be drawn at the time of delivery to determine the mother's HBsAG
					 status; if it is positive, the infant should receive HBIG as soon as possible
					 (no later than 1 wk of age). The dosage and timing of subsequent vaccine doses
					 should be based upon the mother's HBsAg status.
3 Children and adolescents who
					 have not been vaccinated against hepatitis B in infancy may begin the series
					 during any childhood visit. Those who have not previously received 3 doses of
					 hepatitis B vaccine should initiate or complete the series during the 11-12
					 year-old visit. The 2nd dose should be administered at least 1 mo after the 1st
					 dose, and the 3rd dose should be administered at least 4 mos after the 1st
					 dose, and at least 2 mos after the 2nd dose.
4 DTaP (diphtheria and tetanus
					 toxoids and acellular pertussis vaccine) is the preferred vaccine for all doses
					 in the vaccination series, including completion of the series in children who
					 have received >=1 dose of whole-cell DTP vaccine. Whole-cell DTP is an
					 acceptable alternative to DTaP. The 4th dose of DTaP may be administered as
					 early as 12 mos of age, provided 6 mos have elapsed since the 3rd dose, and if
					 the child is considered unlikely to return at 15-18 mos of age. Td (tetanus and
					 diphtheria toxoids, adsorbed, for adult use) is recommended at 11-12 yrs of age
					 if at least 5 yrs have elapsed since the last dose of DTP, DTaP or DT.
					 Subsequent routine Td boosters are recommended every 10 yrs.
5 Three H. influenzae type b
					 (Hib) conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB
					 [Merck]) is administered at 2 and 4 mos of age, a dose at 6 mos is not
					 required. After completing the primary series, any Hib conjugate vaccine may be
					 used as a booster.
6 Two poliovirus vaccines are
					 currently licensed in the US: inactivated poliovirus vaccine (IPV) and oral
					 poliovirus vaccine (OPV). The following schedules are all acceptable by the
					 ACIP, the AAP and the AAFP, and parents and providers may choose among
					 them:
1. IPV at 2 and 4 mos; OPV at 12-18 mos and 4-6 yrs
2. IPV at 2, 4, 12-18 mos, and 4-6 yrs
3. OPV at 2, 4, 6-18 mos, and 4-6 yrs
The ACIP routinely recommends schedule 1. IPV is the only
					 poliovirus vaccine recommended for immunocompromised persons and their
					 household contacts.
7 The 2nd dose of MMR is
					 routinely recommended at 4-6 yrs of age or at 11-12 yrs of age, but may be
					 administered during any visit, provided at least 1 mo has elapsed since receipt
					 of the 1st dose, and that both doses are administered at or after 12 mos of
					 age.
8 Susceptible children may
					 receive Varicella vaccine (Var) during any visit after the 1st birthday, and
					 unvaccinated persons who lack a reliable history of chickenpox should be
					 vaccinated during the 11-12 year-old visit. Susceptible persons >=13 yrs of
					 age should receive 2 doses, at least 1 mo apart.
This appendix cited in 55 Pa. Code §
												1221.51 (relating to general
						payment policy).